Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease

Potential Consequences of Changing Disease Classifications

(2020) Jenny A. Doust et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vascular dysfunction—The disregarded partner of Alzheimer's disease

(2019) Melanie D. Sweeney et al.   Alzheimers & Dementia

Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease

(2019) James A R Nicoll et al.   BRAIN

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

On the reconceptualization of Alzheimer’s disease

(2018) Maartje H. N. Schermer et al.   BIOETHICS

Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

(2017) Steffen Wolfsgruber et al.   JOURNAL OF ALZHEIMERS DISEASE

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Alzheimer's disease

(2016) Philip Scheltens et al.   LANCET

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials

(2014) Reisa Sperling et al.   NEURON

Small Tumors as Risk Factors not Disease

(2014) Peter H. Schwartz   PHILOSOPHY OF SCIENCE

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020

(2013) Harald Hampel et al.   BIOCHEMICAL PHARMACOLOGY

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Preclinical Alzheimer disease—the challenges ahead

(2012) Reisa A. Sperling et al.   Nature Reviews Neurology

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

(2011) Clifford R. Jack et al.   ANNALS OF NEUROLOGY

New lexicon and criteria for the diagnosis of Alzheimer's disease

(2011) Giorgio Giaccone et al.   LANCET NEUROLOGY

Predicting MCI outcome with clinically available MRI and CSF biomarkers

(2011) D. Heister et al.   NEUROLOGY

Desktop Medicine

(2010) Jason Karlawish   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Age, Neuropathology, and Dementia

(2009) George M. Savva et al.   NEW ENGLAND JOURNAL OF MEDICINE